These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 4838913)

  • 21. Interactions of L-dopa and amantadine in patients with Parkinsonism.
    Cox B; Danta G; Schnieden H; Yuill GM
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases].
    Sigwald J; Raymondeaud C
    Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa.
    Zeldowicz LR; Hubermann J
    Can Med Assoc J; 1973 Oct; 109(7):588-93. PubMed ID: 4582563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract]   [Full Text] [Related]  

  • 26. Amantadine for Parkinson's disease.
    Mann DC; Pearce LA; Waterbury LD
    Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H; Gurtner B
    Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
    [No Abstract]   [Full Text] [Related]  

  • 28. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses.
    Fahn S; Isgreen WP
    Neurology; 1975 Aug; 25(8):695-700. PubMed ID: 807869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinsonism, levodopa, and anesthesia.
    Ngai SH
    Anesthesiology; 1972 Sep; 37(3):344-51. PubMed ID: 4559395
    [No Abstract]   [Full Text] [Related]  

  • 31. A second report on Levodopa.
    Med Lett Drugs Ther; 1969 Sep; 11(18):73-5. PubMed ID: 5394281
    [No Abstract]   [Full Text] [Related]  

  • 32. Amantadine in the treatment of Parkinson's disease.
    Schwab RS; England AC; Poskanzer DC; Young RR
    JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715
    [No Abstract]   [Full Text] [Related]  

  • 33. Piribedil (ET 495) in the treatment of Parkinson's disease combined with amantadine or levodopa.
    Callaghan N; Fitzpatrick E; O'Mahony JB
    Acta Neurol Scand; 1975 Sep; 52(3):179-86. PubMed ID: 1098359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of patients with postencephalitic Parkinsonism to levodopa.
    Duvoisin RC; Lobo-Antunes J; Yahr MD
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):487-95. PubMed ID: 5049808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes].
    Ciuca I; Bulandra R; Serbanesco A; Ninosu N
    Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049
    [No Abstract]   [Full Text] [Related]  

  • 36. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 37. Parkinson's disease and amantadine hydrochloride.
    JAMA; 1969 May; 208(7):1180-1. PubMed ID: 5818720
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of parkinsonism by amantadine and levodopa.
    Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE
    Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584
    [No Abstract]   [Full Text] [Related]  

  • 39. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 40. [Present-day treatment of parkinsonism in the aged].
    Siegfried J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.